Title: |
Authors:
|
Abstract: India not only has the world’s highest
annual incidence of TB and the highest TB-related mortality, it also has the
highest number of multi-drug resistant tuberculosis (MDR-TB) cases in the
world. Over the past few years, India has witnessed India a rising trend of MDR
TB cases. It has to be mentioned though that there is a lack of robust
monitoring system and dearth of prevalence studies to estimate the exact burden
of the problem. Treatment success rate of patients with DR-TB was reported to
be below 50% in India, which resulted in higher death rates. There are various
issues related to patient care which has contributed to low treatment success
rate of MDR TB patients. This study has been designed to explore the challenges
with respect to the diagnosis of MDR-TB, access to appropriate treatment and
care, and adherence to treatment basically from a patient’s perspective. The
study was conducted among adults (both males and females) diagnosed with MDR TB
of > 18 years of age and currently on treatment or having completed
treatment within the last 6 months registered in a tuberculosis unit of a rural
district. In depth interview guide and focused group discussion were used to
collect data from study participants. The patients had raised several concerns during
the diagnostic and treatment phase of their treatment. Majority 37 (88%) of the
patients reported difficulties in reaching the proper health care facility for
getting a correct diagnosis of MDR TB. Many of the patients 23 (54.7%)
expressed concern over the irregular supply of drugs for MDR TB treatment. Most
of the patients 38(90.4%) complained of having to face stigma at their work
place mostly after the diagnosis is revealed. All the patients complained that
prolonged and periodic visit to the health centers caused major economic losses
for the families being daily wagers. Most of the patients 32 (76.19%) reported
facing isolation in the society not only for themselves but for their entire
family. A comprehensive approach involving multiple stakeholders is required to
address the root causes of patient related challenges in MDR TB treatment.
DOI: http://dx.doi.org/10.51505/ijmshr.2024.8606 |
PDF Download |